Pathogenesis of liver cirrhosis.
暂无分享,去创建一个
[1] E. Wisse,et al. An electron microscopic study of the fenestrated endothelial lining of rat liver sinusoids. , 1970, Journal of ultrastructure research.
[2] H. Tsukamoto,et al. Sensitization of hepatic lipocytes by high‐fat diet to stimulatory effects of kupffer cell‐derived factors: Implication in alcoholic liver fibrogenesis , 1990, Hepatology.
[3] Yoshiki Murakami,et al. The Progression of Liver Fibrosis Is Related with Overexpression of the miR-199 and 200 Families , 2011, PloS one.
[4] A. Benedetti,et al. An interleukin-1 receptor antagonist decreases fibrosis induced by dimethylnitrosamine in rat liver , 2004, Virchows Archiv.
[5] H. Nishina,et al. Status and prospects of liver cirrhosis treatment by using bone marrow-derived cells and mesenchymal cells. , 2014, Tissue engineering. Part B, Reviews.
[6] Kazuo Ikeda,et al. Induction of microRNA-214-5p in human and rodent liver fibrosis , 2012, Fibrogenesis & tissue repair.
[7] Wei Wu,et al. Efficacy of HGF carried by ultrasound microbubble-cationic nano-liposomes complex for treating hepatic fibrosis in a bile duct ligation rat model, and its relationship with the diffusion-weighted MRI parameters. , 2013, Clinics and research in hepatology and gastroenterology.
[8] Yanqiu Wang,et al. Probucol attenuates ethanol‐induced liver fibrosis in rats by inhibiting oxidative stress, extracellular matrix protein accumulation and cytokine production , 2014, Clinical and experimental pharmacology & physiology.
[9] Terry M. Therneau,et al. Underestimation of liver-related mortality in the United States. , 2013, Gastroenterology.
[10] M. Holmqvist,et al. Long‐term follow‐up of patients with NAFLD and elevated liver enzymes , 2006, Hepatology.
[11] Cheng Huang,et al. The potential of microRNAs in liver fibrosis. , 2012, Cellular signalling.
[12] R. Saller,et al. The Use of Silymarin in the Treatment of Liver Diseases , 2012, Drugs.
[13] A. Scheynius,et al. Kupffer cell iron overload induces intercellular adhesion molecule‐1 expression on hepatocytes in genetic hemochromatosis , 1995, Hepatology.
[14] Z. Kmieć,et al. Cooperation of Liver Cells in Health and Disease , 2001, Advances in Anatomy Embryology and Cell Biology.
[15] T. Luedde,et al. Micro-RNA Profiling in Human Serum Reveals Compartment-Specific Roles of miR-571 and miR-652 in Liver Cirrhosis , 2012, PloS one.
[16] J. Sheng,et al. Efficacy of combined therapy in patients with hepatitis B virus-related decompensated cirrhosis. , 2013, World journal of gastroenterology.
[17] K. Jeong,et al. Hypoxia potentiates transforming growth factor‐β expression of hepatocyte during the cirrhotic condition in rat liver , 2004, Liver international : official journal of the International Association for the Study of the Liver.
[18] A. Gressner,et al. Antisense strategy against PDGF B-chain proves effective in preventing experimental liver fibrogenesis. , 2004, Biochemical and biophysical research communications.
[19] J. Dranoff,et al. Autocrine release of TGF‐β by portal fibroblasts regulates cell growth , 2004 .
[20] M. Shiao,et al. Antifibrotic effects of Salvia miltiorrhiza on dimethylnitrosamine-intoxicated rats. , 2005, Journal of biomedical science.
[21] J. Iredale,et al. Progelatinase A is produced and activated by rat hepatic stellate cells and promotes their proliferation , 1999, Hepatology.
[22] M. Serdar,et al. The effect of taurine treatment on oxidative stress in experimental liver fibrosis. , 2004, Hepatology research : the official journal of the Japan Society of Hepatology.
[23] Xiao-feng Shi,et al. The antifibrotic effects of TGF-β1 siRNA on hepatic fibrosis in rats. , 2011, Biochemical and biophysical research communications.
[24] William M. Lee,et al. Screening for Wilson disease in acute liver failure: A comparison of currently available diagnostic tests , 2008, Hepatology.
[25] L. Sobin,et al. The morphology of cirrhosis. Recommendations on definition, nomenclature, and classification by a working group sponsored by the World Health Organization. , 1978, Journal of clinical pathology.
[26] Junfeng Zhang,et al. 3,3′‐Diindolylmethane ameliorates experimental hepatic fibrosis via inhibiting miR‐21 expression , 2013, British journal of pharmacology.
[27] S. Friedman. The Cellular Basis of Hepatic Fibrosis -- Mechanisms and Treatment Strategies , 1993 .
[28] M. Manns,et al. Hepatocyte telomere shortening and senescence are general markers of human liver cirrhosis , 2002 .
[29] C. Camaschella. Treating iron overload. , 2013, The New England journal of medicine.
[30] D. Schuppan,et al. Hepatitis C and liver fibrosis , 2003, Cell Death and Differentiation.
[31] Y. Inagaki,et al. Treatment strategy for liver fibrosis through recruitment and differentiation of bone marrow stem/progenitor cells , 2007, Hepatology research : the official journal of the Japan Society of Hepatology.
[32] Y. Yamori,et al. Dysregulated Bile Acid Synthesis, Metabolism and Excretion in a High Fat-Cholesterol Diet-Induced Fibrotic Steatohepatitis in Rats , 2013, Digestive Diseases and Sciences.
[33] G. Kolios,et al. Role of Kupffer cells in the pathogenesis of liver disease. , 2006, World journal of gastroenterology.
[34] Gennaro Ciliberto,et al. Increased toxin‐induced liver injury and fibrosis in interleukin‐6–deficient mice , 2000, Hepatology.
[35] Xing-kai Meng,et al. Development of a New Animal Model of Liver Cirrhosis in Swine , 2008, European Surgical Research.
[36] B. Comert,et al. Ursodeoxycholic acid treatment improves hepatocyte ultrastructure in rat liver fibrosis. , 2008, World journal of gastroenterology.
[37] P. Mulder,et al. Depression in patients with primary biliary cirrhosis and primary sclerosing cholangitis. , 2007, Journal of hepatology.
[38] X. Hou,et al. Efficacy and safety of tauroursodeoxycholic acid in the treatment of liver cirrhosis: A double-blind randomized controlled trial , 2013, Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban.
[39] D. Stolz,et al. Arsenic stimulates sinusoidal endothelial cell capillarization and vessel remodeling in mouse liver , 2007, Hepatology.
[40] Yao Tong,et al. Traditional Chinese herbal medicines for treatment of liver fibrosis and cancer: from laboratory discovery to clinical evaluation , 2007, Liver international : official journal of the International Association for the Study of the Liver.
[41] Shi-jun Chen,et al. Expression of Interleukin-17 associated with disease progression and liver fibrosis with hepatitis B virus infection: IL-17 in HBV infection , 2013, Diagnostic Pathology.
[42] T. Luedde,et al. miR-133a mediates TGF-β-dependent derepression of collagen synthesis in hepatic stellate cells during liver fibrosis. , 2013, Journal of hepatology.
[43] D. Schuppan,et al. Progression of liver fibrosis in post-transplant hepatitis C: mechanisms, assessment and treatment. , 2013, Journal of hepatology.
[44] N. Delibaş,et al. Non-invasive tests in prediction of liver fibrosis in chronic hepatitis B and comparison with post-antiviral treatment results. , 2013, Clinics and research in hepatology and gastroenterology.
[45] C. J. Marek,et al. Inhibition of inhibitor of kappaB kinases stimulates hepatic stellate cell apoptosis and accelerated recovery from rat liver fibrosis. , 2005, Gastroenterology.
[46] G. Escobedo,et al. Th2-Associated Alternative Kupffer Cell Activation Promotes Liver Fibrosis without Inducing Local Inflammation , 2011, International journal of biological sciences.
[47] D. Jiang,et al. HGF inhibits TGF-β1-induced myofibroblast differentiation and ECM deposition via MMP-2 in Achilles tendon in rat , 2011, European Journal of Applied Physiology.
[48] A. Colao,et al. Circulating levels of cytochrome C, gamma-glutamyl transferase, triglycerides and unconjugated bilirubin in overweight/obese patients with non-alcoholic fatty liver disease. , 2011, Journal of biological regulators and homeostatic agents.
[49] F. Oakley,et al. The role and regulation of hepatic stellate cell apoptosis in reversal of liver fibrosis , 2005, Apoptosis.
[50] Q. Fa-zu,et al. Studies on hepatocyte apoptosis, proliferation and oncogene c-fos expression in carbon tetrachloride-induced cirrhotic rat liver , 2008, Journal of Tongji Medical University.
[51] Y. Popov. Mouse model of primary biliary cirrhosis with progressive fibrosis: Are we there yet? , 2013, Hepatology.
[52] J. Kountouras,et al. Colchicine treatment of liver fibrosis. , 2006, Hepato-gastroenterology.
[53] S. Pianko,et al. Alcohol consumption induces hepatocyte apoptosis in patients with chronic hepatitis C infection , 2000, Journal of gastroenterology and hepatology.
[54] Y. N. Park,et al. Non-invasive assessment of changes in liver fibrosis via liver stiffness measurement in patients with chronic hepatitis B: impact of antiviral treatment on fibrosis regression , 2010, Hepatology international.
[55] Yi‐Chen Chen,et al. Hepatoprotection of silymarin against thioacetamide-induced chronic liver fibrosis. , 2012, Journal of the science of food and agriculture.
[56] N. Kawada,et al. Effect of natural interferon α on proliferation and apoptosis of hepatic stellate cells , 2009, Hepatology international.
[57] P. Boor,et al. Platelet-derived growth factor (PDGF)-C neutralization reveals differential roles of PDGF receptors in liver and kidney fibrosis. , 2013, The American journal of pathology.
[58] Douglas A. Simonetto,et al. Vascular endothelial growth factor promotes fibrosis resolution and repair in mice. , 2014, Gastroenterology.
[59] G. Brewer,et al. Improvement in Dissolution of Liver Fibrosis in an Animal Model by Tetrathiomolybdate , 2009, Experimental biology and medicine.
[60] Filip Braet,et al. Structural and functional aspects of liver sinusoidal endothelial cell fenestrae: a review , 2002, Comparative hepatology.
[61] J. Miquel,et al. Effect of losartan on early liver fibrosis development in a rat model of nonalcoholic steatohepatitis , 2007, Journal of gastroenterology and hepatology.
[62] B. Violand,et al. Anti‐PDGF‐B monoclonal antibody reduces liver fibrosis development , 2010, Hepatology research : the official journal of the Japan Society of Hepatology.
[63] T. Okanoue,et al. Role of sinusoidal endothelial cells in liver disease , 1995, Journal of gastroenterology and hepatology.
[64] James Q. Yin,et al. Therapeutic strategies against TGF‐β signaling pathway in hepatic fibrosis , 2006 .
[65] H. Ueno,et al. Inhibitory effect of a soluble transforming growth factor beta type II receptor on the activation of rat hepatic stellate cells in primary culture. , 2003, Journal of hepatology.
[66] R. Perez-Tamayo,et al. Hepatocyte production of modulators of extracellular liver matrix in normal and cirrhotic rat liver. , 2006, Experimental and molecular pathology.
[67] Li-juan Zhang,et al. Therapeutic effect of interleukin-10 on CCl4-induced hepatic fibrosis in rats. , 2006, World journal of gastroenterology.
[68] Tao Yu,et al. Effect of rat serum containing Biejiajian oral liquid on proliferation of rat hepatic stellate cells. , 2004, World journal of gastroenterology.
[69] Y. Ngo,et al. Impact of interferon-alpha treatment on liver fibrosis in patients with chronic hepatitis B: an overview of published trials. , 2009, Gastroenterologie clinique et biologique.
[70] Y. Chrétien,et al. Development of autoimmune hepatitis in patients with typical primary biliary cirrhosis , 2006, Hepatology.
[71] D. Jäger,et al. Liver specific deletion of CYLDexon7/8 induces severe biliary damage, fibrosis and increases hepatocarcinogenesis in mice. , 2012, Journal of hepatology.
[72] Y. Liaw,et al. Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update , 2008, Hepatology international.
[73] S. Hung,et al. The therapeutic potential of human umbilical mesenchymal stem cells from Wharton's jelly in the treatment of rat liver fibrosis , 2009, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[74] J. Reichen,et al. Low-dose oral rapamycin treatment reduces fibrogenesis, improves liver function, and prolongs survival in rats with established liver cirrhosis. , 2006, Journal of hepatology.
[75] G. Ji,et al. Effect of Chinese medicine Qinggan Huoxuefang on inducing HSC apoptosis in alcoholic liver fibrosis rats. , 2006, World journal of gastroenterology.
[76] Y. Perrie,et al. Targeted delivery of a novel group of site-directed transglutaminase inhibitors to the liver using liposomes: a new approach for the potential treatment of liver fibrosis , 2011, Journal of drug targeting.
[77] Youxin Jin,et al. Inhibition of connective tissue growth factor by siRNA prevents liver fibrosis in rats , 2006, The journal of gene medicine.
[78] M. Tsai,et al. Phyto-power dietary supplement potently inhibits dimethylnitrosamine-induced liver fibrosis in rats. , 2013, Food & function.
[79] H. Cortez‐Pinto,et al. Hepatocyte Apoptosis, Expression of Death Receptors, and Activation of NF-κB in the Liver of Nonalcoholic and Alcoholic Steatohepatitis Patients , 2004, The American Journal of Gastroenterology.
[80] K. Guo,et al. miR-181b promotes hepatic stellate cells proliferation by targeting p27 and is elevated in the serum of cirrhosis patients. , 2012, Biochemical and biophysical research communications.
[81] PDGF and signal transduction in hepatic stellate cells. , 2002 .
[82] K. Goh,et al. Liver cirrhosis in Malaysia: Peculiar epidemiology in a multiracial Asian country , 2011, Journal of gastroenterology and hepatology.
[83] X. Coumoul,et al. Aryl hydrocarbon receptor-dependent induction of liver fibrosis by dioxin. , 2014, Toxicological sciences : an official journal of the Society of Toxicology.
[84] D. Stolz. Sinusoidal Endothelial Cells , 2011 .
[85] J. Spitzer,et al. Hepatic sinusoidal endothelial cell in alcoholemia and endotoxemia. , 1996, Alcoholism, clinical and experimental research.
[86] S. Vowler,et al. Relation between hepatocyte G1 arrest, impaired hepatic regeneration, and fibrosis in chronic hepatitis C virus infection. , 2005, Gastroenterology.
[87] A. Gressner,et al. Pro-fibrogenic potential of PDGF-D in liver fibrosis. , 2007, Journal of hepatology.
[88] Ioannis I. Stamoulis,et al. Platelet-Activating Factor Involvement in Thioacetamide-Induced Experimental Liver Fibrosis and Cirrhosis , 2010, Digestive Diseases and Sciences.
[89] A. Concejero,et al. Electroporative interleukin-10 gene transfer ameliorates carbon tetrachloride-induced murine liver fibrosis by MMP and TIMP modulation , 2006, Acta Pharmacologica Sinica.
[90] Edoardo Cervoni,et al. Hepatitis C , 1998, The Lancet.
[91] R. Malekzadeh,et al. Impact of Immunosuppressive Treatment on Liver Fibrosis in Autoimmune Hepatitis , 2005, Digestive Diseases and Sciences.
[92] R Weiskirchen,et al. Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-β as major players and therapeutic targets , 2006, Journal of cellular and molecular medicine.
[93] A. Işık,et al. Pegylated interferon-alpha plus taurine in treatment of rat liver fibrosis. , 2007, World journal of gastroenterology.
[94] R. Coppel,et al. Primary biliary cirrhosis , 2011, The Lancet.
[95] E. De Clercq,et al. Ribavirin and mycophenolic acid markedly potentiate the anti-hepatitis B virus activity of entecavir. , 2007, Antiviral research.
[96] C. Liu,et al. Clinical observation of salvianolic acid B in treatment of liver fibrosis in chronic hepatitis B. , 2002, World journal of gastroenterology.
[97] Ying-Jan Wang,et al. α-Lipoic acid inhibits liver fibrosis through the attenuation of ROS-triggered signaling in hepatic stellate cells activated by PDGF and TGF-β. , 2011, Toxicology.
[98] K. Yoshimura,et al. Recent advances in liver sinusoidal endothelial ultrastructure and fine structure immunocytochemistry. , 2012, Micron.
[99] M. Sherman,et al. Regression of human cirrhosis. Morphologic features and the genesis of incomplete septal cirrhosis. , 2000, Archives of pathology & laboratory medicine.
[100] B. Saile. The bcl, NFκB and p53/p21WAF1 systems are involved in spontaneous apoptosis and in the anti-apoptotic effect of TGF-β or TNF-α on activated hepatic stellate cells , 2001 .
[101] R. Malekzadeh,et al. Review article: the reversibility of cirrhosis , 2012, Alimentary pharmacology & therapeutics.
[102] R. Mahato,et al. Gene modulation for treating liver fibrosis. , 2007, Critical reviews in therapeutic drug carrier systems.
[103] B. Bacon,et al. Hereditary hemochromatosis in the post‐HFE era , 2008, Hepatology.
[104] S. Friedman,et al. Hepatic fibrosis--role of hepatic stellate cell activation. , 2002, MedGenMed : Medscape general medicine.
[105] G. Kanel,et al. Role of differentiation of liver sinusoidal endothelial cells in progression and regression of hepatic fibrosis in rats. , 2012, Gastroenterology.
[106] L. Packer,et al. α-Lipoic Acid , 2000 .
[107] J. Lunz,et al. An inhibitor of cyclin‐dependent kinase, stress‐induced p21Waf‐1/Cip‐1, mediates hepatocyte mito‐inhibition during the evolution of cirrhosis , 2005, Hepatology.
[108] Yong-ri Jin,et al. Treatment of pig serum-induced rat liver fibrosis with Boschniakia rossica, oxymatrine and interferon-alpha. , 2005, World journal of gastroenterology.
[109] D. Bar-Sagi,et al. In liver fibrosis, dendritic cells govern hepatic inflammation in mice via TNF-alpha. , 2009, The Journal of clinical investigation.
[110] G. Gores,et al. Activated stellate cells express the TRAIL receptor‐2/death receptor‐5 and undergo TRAIL‐mediated apoptosis , 2003, Hepatology.
[111] H. Tsukamoto,et al. Stimulation of hepatic lipocyte collagen production by Kupffer cell‐derived transforming growth factor β: Implication for a pathogenetic role in alcoholic liver fibrogenesis , 1990, Hepatology.
[112] Fortunato,et al. Alcohol-induced sinusoidal endothelial cell dysfunction in the mouse is associated with exacerbated liver apoptosis and can be reversed by caspase inhibition. , 2001, Hepatology research : the official journal of the Japan Society of Hepatology.
[113] K. Tsuneyama,et al. Innate immunity and primary biliary cirrhosis: Activated invariant natural killer T cells exacerbate murine autoimmune cholangitis and fibrosis , 2011, Hepatology.
[114] G. Ramadori,et al. Interferon-gamma acts proapoptotic on hepatic stellate cells (HSC) and abrogates the antiapoptotic effect of interferon-alpha by an HSP70-dependant pathway. , 2005, European journal of cell biology.
[115] H. Bonkovsky,et al. Inhibitory effects of microRNA 19b in hepatic stellate cell‐mediated fibrogenesis , 2012, Hepatology.
[116] G. Gores,et al. Kupffer cell engulfment of apoptotic bodies stimulates death ligand and cytokine expression , 2003, Hepatology.
[117] I. Barshack,et al. Lack of interleukin-1α or interleukin-1β inhibits transformation of steatosis to steatohepatitis and liver fibrosis in hypercholesterolemic mice. , 2011, Journal of hepatology.
[118] L. Ferrell. Liver Pathology: Cirrhosis, Hepatitis, and Primary Liver Tumors. Update and Diagnostic Problems , 2000, Modern Pathology.
[119] P. Schirmacher,et al. Spontaneous hepatic fibrosis in transgenic mice overexpressing PDGF-A. , 2008, Gene.
[120] M. Zern,et al. Inhibitory effect of glycyrrhizin on NF-kappaB binding activity in CCl4- plus ethanol-induced liver cirrhosis in rats. , 2008, Liver.
[121] V. Alves,et al. S-nitroso-N-acetylcysteine attenuates liver fibrosis in experimental nonalcoholic steatohepatitis , 2013, Drug design, development and therapy.
[122] Cheng-Hai Liu,et al. Salvianolic acid B inhibits hepatic stellate cell activation through transforming growth factor beta-1 signal transduction pathway in vivo and in vitro , 2013, Experimental biology and medicine.
[123] Natalie J Torok,et al. Liver fibrosis causes downregulation of miRNA-150 and miRNA-194 in hepatic stellate cells, and their overexpression causes decreased stellate cell activation. , 2010, American journal of physiology. Gastrointestinal and liver physiology.
[124] B. Gao,et al. Interleukin‐22 induces hepatic stellate cell senescence and restricts liver fibrosis in mice , 2012, Hepatology.
[125] D. Schuppan,et al. Increased hepatic fibrosis and JNK2-dependent liver injury in mice exhibiting hepatocyte-specific deletion of cFLIP. , 2012, American journal of physiology. Gastrointestinal and liver physiology.
[126] R. Urtasun,et al. Osteopontin induces ductular reaction contributing to liver fibrosis , 2014, Gut.
[127] K. Okita,et al. Pioglitazone prevents hepatic steatosis, fibrosis, and enzyme-altered lesions in rat liver cirrhosis induced by a choline-deficient L-amino acid-defined diet. , 2004, Biochemical and biophysical research communications.
[128] Wen-Chuan Lin,et al. Post‐treatment of Ganoderma lucidum reduced liver fibrosis induced by thioacetamide in mice , 2009, Phytotherapy research : PTR.
[129] J. Crespo,et al. Plasma Leptin and TNF-α Levels in Chronic Hepatitis C Patients and Their Relationship to Hepatic Fibrosis , 2002, Digestive Diseases and Sciences.
[130] T. Hibi,et al. Tumour necrosis factor α signalling through activation of Kupffer cells plays an essential role in liver fibrosis of non-alcoholic steatohepatitis in mice , 2005, Gut.
[131] V. Tsutsumi,et al. Antifibrotic and fibrolytic properties of celecoxib in liver damage induced by carbon tetrachloride in the rat , 2010, Liver international : official journal of the International Association for the Study of the Liver.
[132] Rongbo Zhang,et al. Vitamin E reduces hepatic fibrosis in mice with Schistosoma japonicum infection. , 2011, Molecular medicine reports.
[133] Chuanlong Zhu,et al. Inhibitory Effect of Antisense Oligonucleotide Targeting TIMP-2 on Immune-Induced Liver Fibrosis , 2010, Digestive Diseases and Sciences.
[134] Kun-Lin Yang,et al. Establishment of an early liver fibrosis model by the hydrodynamics-based transfer of TGF-β1 gene , 2007, Comparative hepatology.
[135] Shaheen N. Khan,et al. Mesenchymal stem cells and Interleukin-6 attenuate liver fibrosis in mice , 2013, Journal of Translational Medicine.
[136] I. Kamel,et al. Non-alcoholic fatty liver disease and mortality among US adults: prospective cohort study , 2011, BMJ : British Medical Journal.
[137] A. Bisceglie. Natural history of hepatitis C: its impact on clinical management. , 2000 .
[138] Hui Wang,et al. Protective effect of verapamil on multiple hepatotoxic factors-induced liver fibrosis in rats. , 2007, Pharmacological research.
[139] A. Lok,et al. Update on viral hepatitis: 2007 , 2008, Current opinion in gastroenterology.
[140] E. Kouroumalis,et al. Octreotide modulates the effects on fibrosis of TNF-α, TGF-β and PDGF in activated rat hepatic stellate cells , 2014, Regulatory Peptides.
[141] M. Odenthal,et al. Hepatic and serum levels of miR-122 after chronic HCV-induced fibrosis. , 2013, Journal of hepatology.
[142] G. Perlemuter,et al. [Epidemiology and natural history of cirrhosis]. , 2005, La Revue du praticien.
[143] P. Hayes,et al. Quantifying the fraction of cirrhosis attributable to alcohol among chronic hepatitis C virus patients: Implications for treatment cost‐effectiveness , 2013, Hepatology.
[144] Ying-wei Chen,et al. Tetrandrine inhibits activation of rat hepatic stellate cells in vitro via transforming growth factor-beta signaling. , 2005, World journal of gastroenterology.
[145] M. Menger,et al. Microvascular consequences of Kupffer cell modulation in rat liver fibrogenesis , 1999, The Journal of pathology.
[146] Li-juan Zhang,et al. Antifibrotic effects of interleukin-10 on experimental hepatic fibrosis. , 2007, Hepato-gastroenterology.
[147] D. Crane,et al. Excess iron modulates endoplasmic reticulum stress-associated pathways in a mouse model of alcohol and high-fat diet-induced liver injury , 2013, Laboratory Investigation.
[148] Kaori Fujieda,et al. Capillarization and venularization of hepatic sinusoids in porcine serum‐induced rat liver fibrosis: A mechanism to maintain liver blood flow , 1993, Hepatology.
[149] Ming-Fen Lee,et al. Pterostilbene inhibits dimethylnitrosamine (DMN)‐induced liver fibrosis in rats , 2012, Food chemistry.
[150] H. Ran,et al. The treatment of liver fibrosis induced by hepatocyte growth factor-directed, ultrasound-targeted microbubble destruction in rats. , 2009, Clinical imaging.
[151] Y. Li,et al. Preventive Effect of Halofuginone on Concanavalin A-Induced Liver Fibrosis , 2013, PloS one.
[152] K. Kodys,et al. IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice. , 2012, The Journal of clinical investigation.
[153] K. Wallace,et al. Interleukin-1 participates in the progression from liver injury to fibrosis. , 2009, American Journal of Physiology - Gastrointestinal and Liver Physiology.
[154] G. Ramadori,et al. IGF-I induces DNA synthesis and apoptosis in rat liver hepatic stellate cells (HSC) but DNA synthesis and proliferation in rat liver myofibroblasts (rMF) , 2004, Laboratory Investigation.
[155] Y. Tong,et al. Chinese medicines as a resource for liver fibrosis treatment , 2009, Chinese medicine.
[156] J. Lin,et al. Inhibition by curcumin of diethylnitrosamine-induced hepatic hyperplasia, inflammation, cellular gene products and cell-cycle-related proteins in rats. , 2000, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[157] A. Benedetti,et al. Interferon gamma decreases hepatic stellate cell activation and extracellular matrix deposition in rat liver fibrosis , 1996, Hepatology.
[158] R. Khan,et al. Update on Viral Hepatitis , 1997, Journal of the Royal College of Physicians of London.
[159] J. Koskinas,et al. Autoimmune Hepatitis or Wilson’s Disease, a Clinical Dilemma , 2013, Hepatitis monthly.
[160] Jianming Xu,et al. Melatonin ameliorates experimental hepatic fibrosis induced by carbon tetrachloride in rats. , 2009, World journal of gastroenterology.
[161] T. Okanoue,et al. Defenestration of the sinusoidal endothelial cell in a rat model of cirrhosis , 1993, Hepatology.
[162] Ping Liu. Fuzheng Huayu Capsule (扶正化瘀胶囊) in the treatment of liver fibrosis: Clinical evidence and mechanism of action , 2012, Chinese Journal of Integrative Medicine.
[163] A. Chowdhury,et al. Development of an animal model of hepatic fibrosis by excretory-secretory antigen of Ascaris suum. , 2000, Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology.
[164] A. Colao,et al. Hepatic steatosis, low-grade chronic inflammation and hormone/growth factor/adipokine imbalance. , 2010, World journal of gastroenterology.
[165] H. Gascan,et al. Interleukin-33 overexpression is associated with liver fibrosis in mice and humans , 2009, Journal of cellular and molecular medicine.
[166] W. Hur,et al. Target specific systemic delivery of TGF-β siRNA/(PEI-SS)-g-HA complex for the treatment of liver cirrhosis. , 2011, Biomaterials.
[167] A. Gressner,et al. Dominant-negative soluble PDGF-β receptor inhibits hepatic stellate cell activation and attenuates liver fibrosis , 2004, Laboratory Investigation.
[168] S. Friedman,et al. Activation of cultured rat hepatic lipocytes by Kupffer cell conditioned medium. Direct enhancement of matrix synthesis and stimulation of cell proliferation via induction of platelet-derived growth factor receptors. , 1989, The Journal of clinical investigation.
[169] H. Fujii,et al. Interleukin-17A plays a pivotal role in cholestatic liver fibrosis in mice. , 2013, The Journal of surgical research.
[170] K. Orita,et al. Assessment of Kupffer cell function in rats with chronic liver injury caused by CCl4. , 1990, Hepato-gastroenterology.
[171] A. Colao,et al. Serum Bcl-2 concentrations in overweight-obese subjects with nonalcoholic fatty liver disease. , 2011, World journal of gastroenterology.
[172] E. Terzioğlu,et al. Serum transforming growth factor-beta1(TGF-beta1) in patients with cirrhosis, chronic hepatitis B and chronic hepatitis C [corrected]. , 2004, European cytokine network.
[173] P. Schirmacher,et al. Liver fibrosis induced by hepatic overexpression of PDGF-B in transgenic mice. , 2006, Journal of hepatology.
[174] T. Kishimoto. IL-6: from its discovery to clinical applications. , 2010, International immunology.
[175] A. Gerbes,et al. Kupffer cell activation in normal and fibrotic livers increases portal pressure via thromboxane A(2). , 2007, Journal of hepatology.
[176] S. Du,et al. Houttuynia cordata inhibits lipopolysaccharide-induced rapid pulmonary fibrosis by up-regulating IFN-γ and inhibiting the TGF-β1/Smad pathway , 2012, International Immunopharmacology.
[177] L. DeLeve,et al. Sinusoidal endothelial cells prevent rat stellate cell activation and promote reversion to quiescence , 2008, Hepatology.
[178] M. Zheng,et al. A New Strategy for Treatment of Liver Fibrosis , 2012, BioDrugs.
[179] D. Mukhopadhyay,et al. Neuropilin-1 promotes cirrhosis of the rodent and human liver by enhancing PDGF/TGF-beta signaling in hepatic stellate cells. , 2010, The Journal of clinical investigation.
[180] D. Brenner,et al. Erratum: Liver fibrosis (Journal of Clinical Investigation (2005) 115 (209-218) DOI:10.1172/JCI200524282) , 2005 .
[181] M. Nam,et al. Therapeutic effects of hepatocyte growth factor‐overexpressing human umbilical cord blood‐derived mesenchymal stem cells on liver fibrosis in rats , 2014, Cell biology international.
[182] G. Davis,et al. Interleukin 10 treatment reduces fibrosis in patients with chronic hepatitis C: a pilot trial of interferon nonresponders. , 2000, Gastroenterology.
[183] K. Iwaisako,et al. Interleukin-17 signaling in inflammatory, Kupffer cells, and hepatic stellate cells exacerbates liver fibrosis in mice. , 2012, Gastroenterology.
[184] A. Gruhler,et al. Rat liver sinusoidal endothelial cells (LSECs) express functional low density lipoprotein receptor-related protein-1 (LRP-1). , 2011, Journal of hepatology.
[185] K. Yoshizato,et al. MicroRNA-221/222 upregulation indicates the activation of stellate cells and the progression of liver fibrosis , 2012, Gut.
[186] K. Şahin,et al. The Treatment with Antibody of TNF-α Reduces the Inflammation, Necrosis and Fibrosis in the Non-alcoholic Steatohepatitis Induced by Methionine- and Choline-deficient Diet , 2008, Inflammation.
[187] M. Arthur,et al. Reversibility of liver fibrosis and cirrhosis following treatment for hepatitis C. , 2002, Gastroenterology.
[188] D. Ganem,et al. Hepatitis B virus infection--natural history and clinical consequences. , 2004, The New England journal of medicine.
[189] D. Brenner,et al. Hepatic Stellate Cells as a Target for the Treatment of Liver Fibrosis , 2001, Seminars in liver disease.
[190] Feng Li,et al. Targeted delivery of drugs for liver fibrosis , 2009 .
[191] M. Varela-Rey,et al. Glutathione depletion is involved in the inhibition of procollagen α1(I) mRNA levels caused by TNF-α on hepatic stellate cells , 2007 .
[192] D. Dowling. Screening for Wilson's disease in acute liver failure: A comparison of currently available diagnostic tests , 2009, Hepatology.
[193] Lai Wei,et al. Inhibitory effect of human interferon‐beta‐1a on activated rat and human hepatic stellate cells , 2010, Journal of gastroenterology and hepatology.
[194] T. Luedde,et al. Micro‐RNA profiling reveals a role for miR‐29 in human and murine liver fibrosis , 2011, Hepatology.
[195] G. Tarantino,et al. Could inflammatory markers help diagnose nonalcoholic steatohepatitis? , 2009, European journal of gastroenterology & hepatology.
[196] A. de Gottardi,et al. Long-Term Treatment of Bile Duct-Ligated Rats with Rapamycin (Sirolimus) Significantly Attenuates Liver Fibrosis: Analysis of the Underlying Mechanisms , 2005, Journal of Pharmacology and Experimental Therapeutics.
[197] A. Burt,et al. Fibrosis and cirrhosis reversibility - molecular mechanisms. , 2008, Clinics in liver disease.